Tranilast NEGPF

Tranilast NEGPF Uses, Dosage, Side Effects, Food Interaction and all others data.

Tranilast NEGPF is an antiallergic drug developed by Kissei Pharmaceuticals. In 1982, it was approved in Japan and South Korea for the management of bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.

Table Of contents

• Tranilast NEGPF
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Tranilast NEGPF
Generic	Tranilast
Tranilast Other Names	Tranilast, Tranilastum
Type
Formula	C18H17NO5
Weight	Average: 327.3313 Monoisotopic: 327.110672659
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country	China
Last Updated:	September 19, 2023 at 7:00 am

Uses

For the treatment of bronchial asthma, keloid and hypertrophic scar, and allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.

Innovators Monograph

You find simplified version here Tranilast NEGPF